Leucine-rich repeats and pathogen recognition in Toll-like receptors

Trends in Immunology

Volumn 24, Issue 10, 2003, Pages 528-533

  Bell, Jessica K ^a   Mullen, Gregory E D ^a,b   Leifer, Cynthia A ^b   Mazzoni, Alessandra ^b   Davies, David R ^a   Segal, David M ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LEUCINE; LIGAND; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

BETA SHEET; BINDING SITE; CELL SURFACE; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; CONSENSUS SEQUENCE; HUMAN; INFLAMMATION; LIGAND BINDING; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE REPEAT; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; TANDEM REPEAT; X RAY CRYSTALLOGRAPHY;

EID: 0141559415     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00242-4     Document Type: Article

References (35)

1. Fluhr R., Kaplan-Levy R.N. Plant disease resistance: commonality and novelty in multicellular innate immunity. Curr. Top. Microbiol. Immunol. 270:2002;23-46.
2. Takeda K., et al. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
3. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23:2002;509-512.
4. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3:2003;169-176.
5. Bauer S., Wagner H. Bacterial CpG-DNA licenses TLR9. Curr. Top. Microbiol. Immunol. 270:2002;145-154.
6. Latz E., et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277:2002;47834-47843.
7. Mizel S.B., et al. Induction of macrophage nitric oxide production by gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J. Immunol. 170:2003;6217-6223.
8. Spitzer J.H., et al. Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells. Eur. J. Immunol. 32:2002;1182-1187.
9. O'Neill L.A., et al. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:2003;286-289.
10. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11:2001;725-732.
11. Huizinga E.G., et al. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science. 297:2002;1176-1179.
12. Schubert W.D., et al. Internalins from the human pathogen Listeria monocytogenes combine three distinct folds into a contiguous internalin domain. J. Mol. Biol. 312:2001;783-794.
13. Schubert W.D., et al. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell. 111:2002;825-836.
14. He X.L., et al. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron. 38:2003;177-185.
15. Kajava A.V., Kobe B. Assessment of the ability to model proteins with leucine-rich repeats in light of the latest structural information. Protein Sci. 11:2002;1082-1090.
16. Takahashi N., et al. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich α2-glycoprotein of human serum. Proc. Natl. Acad. Sci. U. S. A. 82:1985;1906-1910.
17. Buchanan S.G., Gay N.J. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65:1996;1-44.
18. Kobe B., Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature. 366:1993;751-756.
19. Uff S., et al. Crystal structure of the platelet glycoprotein Ib(α) N-terminal domain reveals an unmasking mechanism for receptor activation. J. Biol. Chem. 277:2002;35657-35663.
20. Kobe B., Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol. 264:1996;1028-1043.
21. Papageorgiou A.C., et al. Molecular recognition of human angiogenin by placental ribonuclease inhibitor - an X-ray crystallographic study at 2.0 Å resolution. EMBO J. 16:1997;5162-5177.
22. Seewald M.J., et al. RanGAP mediates GTP hydrolysis without an arginine finger. Nature. 415:2002;662-666.
23. Lee J.H., et al. Identification and characterization of the DNA binding domain of CpG-binding protein. J. Biol. Chem. 276:2001;44669-44676.
24. Lazarus R., et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics. 81:2003;85-91.
25. Mizel S.B., et al. Identification of a sequence in human Toll-like receptor 5 required for the binding of gram-negative flagellin. J. Biol. Chem. 278:2003;23624-23629.
26. Henneke P., Golenbock D.T. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit. Care Med. 30:2002;S207-S213.
27. Kobe B., Kajava A.V. When protein folding is simplified to protein coiling: the continuum of solenoid protein structures. Trends Biochem. Sci. 25:2000;509-515.
28. Arbour N.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:2000;187-191.
29. Erridge C., et al. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197:2003;1787-1791.
30. Hajjar A.M., et al. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359.
31. de Haas C.J., et al. Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. Infect. Immun. 67:1999;2790-2796.
32. Schneider D.S., et al. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev. 5:1991;797-807.
33. Kobe B., Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem. Sci. 19:1994;415-421.
34. Davies D.R., Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7-12.
35. Xu Y., et al. Structural basis for signal transduction by Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.